▁Chron 10.375
ic 5.515625
▁pain 11.6953125
▁is 5.51953125
▁still 6.25390625
▁considered 5.0234375
▁to 1.7294921875
▁be 0.451904296875
▁an 3.009765625
▁extreme 5.953125
▁issue 7.390625
▁among 7.3359375
▁at 6.82421875
▁least 1.4130859375
▁ 2.650390625
8 3.197265625
% 4.3125
▁of 1.8544921875
▁the 1.2421875
▁residents 6.89453125
▁of 2.296875
▁progress 9.40625
ive 0.99169921875
▁countries 6.90625
. 2.11328125
▁The 2.5078125
▁introduction 7.234375
▁of 0.25830078125
▁the 1.607421875
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0625
▁link 6.33203125
▁between 0.53515625
▁pain 6.2734375
▁and 0.7490234375
▁dem 8.375
oral 3.49609375
ization 0.27978515625
. 1.45703125
▁Chron 6.23046875
ic 0.029052734375
▁pain 0.311767578125
▁is 1.3017578125
▁always 6.3828125
▁accompanied 2.1953125
▁by 0.05841064453125
▁negative 4.90234375
▁emot 1.48046875
ional 1.326171875
▁experiences 2.96875
▁and 2.126953125
▁blocks 11.0546875
▁a 4.15625
▁person 1.4091796875
’ 24.859375
s 1.9931640625
▁ability 1.8583984375
▁to 0.047119140625
▁receive 6.29296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.2158203125
▁life 1.0341796875
. 0.32421875
▁The 1.8876953125
▁research 3.91796875
▁investig 5.296875
ates 0.45458984375
▁the 0.4833984375
▁development 5.91015625
▁of 0.1756591796875
▁de 3.8359375
pression 0.254638671875
▁and 1.283203125
▁anx 2.25
iety 0.0048980712890625
▁among 2.36328125
▁patients 2.458984375
▁receiving 4.5
▁ph 6.62890625
arma 1.779296875
ce 0.00856781005859375
ut 0.0004601478576660156
ical 0.01070404052734375
▁op 5.05078125
io 0.1884765625
ids 0.63330078125
▁and 2.380859375
▁medical 6.17578125
▁mar 1.498046875
iju 0.04840087890625
ana 0.00019490718841552734
▁( 4.39453125
MM 0.68603515625
) 3.45703125
▁as 2.83984375
▁severe 9.9140625
▁pain 1.619140625
kill 3.0859375
ers 0.0019063949584960938
. 0.52880859375
▁It 3.236328125
▁comp 5.12890625
ares 0.0516357421875
▁the 0.630859375
▁effic 6.4140625
acy 0.00815582275390625
▁of 0.27734375
▁pres 5.1015625
cri 1.7626953125
ptions 0.6923828125
▁and 2.298828125
▁exam 5.8125
ines 0.0113067626953125
▁the 0.44921875
▁possibility 3.794921875
▁of 0.1077880859375
▁post 7.20703125
- 0.67822265625
tre 2.50390625
at 0.024688720703125
ment 0.00739288330078125
▁de 1.8271484375
pression 0.1024169921875
. 1.755859375
▁There 5.1484375
▁is 0.70556640625
▁currently 5.01171875
▁a 1.2392578125
▁severe 5.21875
▁lack 3.048828125
▁of 0.033111572265625
▁information 2.142578125
▁about 1.431640625
▁the 0.560546875
▁effects 3.228515625
▁of 0.0775146484375
▁op 1.9521484375
i 3.951171875
ates 0.348388671875
. 3.7578125
▁A 3.91015625
▁more 5.29296875
▁manage 9.34375
able 0.00531768798828125
▁and 2.04296875
▁sa 2.41796875
fer 0.00238037109375
▁alternative 1.8798828125
▁might 5.23828125
▁be 0.2744140625
▁medical 2.287109375
▁mar 0.298095703125
iju 0.0207977294921875
ana 0.0007715225219726562
. 0.91796875
▁They 5.90234375
▁manage 8.2734375
▁pain 2.642578125
▁successfully 5.30859375
, 1.6025390625
▁but 1.251953125
▁the 2.623046875
▁past 8.90625
▁few 3.466796875
▁dec 1.474609375
ades 0.0003428459167480469
▁indicated 8.546875
▁the 2.275390625
▁growing 4.75
▁concern 4.484375
▁regarding 2.681640625
▁op 3.51171875
iate 0.8076171875
▁ab 1.9208984375
use 0.0179290771484375
▁in 3.236328125
▁forms 11.28125
▁of 0.472900390625
▁over 3.22265625
d 0.47998046875
ose 0.2119140625
▁and 0.77197265625
▁add 1.5556640625
iction 0.023834228515625
. 0.2320556640625
▁However 4.45703125
, 0.01409912109375
▁the 1.599609375
▁legal 5.3046875
▁status 2.189453125
▁and 2.916015625
▁novel 8.375
ty 0.916015625
▁of 0.247802734375
▁this 3.095703125
▁drug 2.78515625
▁do 5.3984375
▁not 0.1627197265625
▁allow 1.6484375
▁finding 8.734375
▁a 2.04296875
▁large 5.3203125
▁number 1.6337890625
▁of 0.00994873046875
▁studies 1.6669921875
▁on 1.61328125
▁its 1.1181640625
▁effect 2.57421875
iveness 0.424560546875
. 0.9765625
▁Specifically 7.5625
, 0.11529541015625
▁it 2.740234375
▁concerns 5.35546875
▁the 0.69140625
▁emot 7.2578125
ional 0.0181884765625
▁condition 5.28515625
▁of 0.4150390625
▁patients 0.83544921875
▁experien 6.34375
cing 0.00022459030151367188
▁chron 1.1826171875
ic 0.0034503936767578125
▁pain 0.149658203125
. 0.92578125
▁This 3.216796875
▁research 3.337890625
▁paper 6.078125
▁a 2.69140625
ims 0.0010519027709960938
▁to 0.10467529296875
▁analyze 3.484375
▁levels 9.7734375
▁of 0.040924072265625
▁de 0.77099609375
pression 0.0361328125
▁and 0.400390625
▁anx 0.05194091796875
iety 0.0026340484619140625
▁among 0.841796875
▁people 3.21875
▁receiving 0.94384765625
▁ther 8.03125
apy 0.50537109375
▁by 5.0390625
▁comparing 8.015625
▁the 1.1123046875
▁effects 2.255859375
▁of 0.032470703125
▁ph 2.412109375
arma 0.053131103515625
ce 0.002651214599609375
ut 7.832050323486328e-05
ical 0.01468658447265625
▁op 0.418701171875
io 0.150634765625
ids 0.07049560546875
▁and 0.281494140625
▁MM 1.5517578125
. 1.2734375
▁Part 5.84375
icip 0.91455078125
ants 0.042724609375
▁were 1.599609375
▁rec 3.09375
ru 0.0006556510925292969
ited 7.081031799316406e-05
▁for 3.345703125
▁six 6.83203125
▁months 0.9404296875
▁at 3.328125
▁two 2.689453125
▁major 5.2265625
▁pain 1.8037109375
▁relief 4.9375
▁cent 1.5654296875
ers 0.0880126953125
▁in 0.76220703125
▁Israel 3.82421875
. 0.462890625
▁The 1.4111328125
▁study 2.0546875
▁was 2.083984375
▁conducted 1.181640625
▁in 1.521484375
▁the 2.169921875
▁form 2.087890625
▁of 0.00868988037109375
▁collection 9.578125
▁and 2.16015625
▁analysis 1.1552734375
▁of 0.06878662109375
▁statistical 4.6796875
▁data 0.2171630859375
. 0.90869140625
▁To 5.16796875
▁specifically 10.1328125
▁evaluate 3.833984375
▁and 3.83203125
▁compare 1.0361328125
▁the 0.428955078125
▁prob 11.09375
abilities 0.75146484375
▁of 0.180908203125
▁de 1.0615234375
pression 0.045166015625
▁or 4.5234375
▁anx 0.042083740234375
iety 0.0010967254638671875
▁among 1.7021484375
▁the 2.5625
▁diverse 8.890625
▁groups 2.017578125
, 2.013671875
▁the 1.431640625
▁study 2.5390625
▁used 2.244140625
▁multiple 4.71875
▁log 3.447265625
istic 0.137451171875
▁regression 0.1453857421875
▁analysis 0.7900390625
▁and 2.615234375
▁chose 8.8125
▁medical 6.98046875
▁mar 0.326904296875
iju 0.00585174560546875
ana 0.00016677379608154297
▁as 0.9169921875
▁the 1.1708984375
▁control 2.95703125
▁group 0.81640625
. 0.326416015625
▁The 1.015625
▁research 2.599609375
ers 2.677734375
▁used 2.634765625
▁The 7.32421875
▁De 4.69921875
pression 0.0479736328125
▁Module 9.0078125
▁of 1.2255859375
▁the 0.404296875
▁Pat 2.724609375
ient 0.008819580078125
▁Health 0.1370849609375
▁Question 0.1468505859375
naire 0.034759521484375
▁and 3.078125
▁the 0.84765625
▁General 1.587890625
ized 0.25146484375
▁An 0.23681640625
x 0.0008072853088378906
iety 0.00856781005859375
▁Dis 0.74169921875
order 0.0389404296875
▁Sc 1.8564453125
ale 0.06787109375
▁to 1.5029296875
▁interview 7.73046875
▁participants 1.958984375
, 3.564453125
▁evaluate 5.35546875
▁their 0.9619140625
▁answers 5.94140625
, 0.7314453125
▁and 0.1441650390625
▁conduct 4.6484375
▁the 2.3203125
▁study 2.2578125
. 0.319580078125
▁This 3.658203125
▁type 5.37890625
▁of 0.01131439208984375
▁study 1.9794921875
▁is 1.34765625
▁the 3.318359375
▁most 1.67578125
▁reve 9.2421875
aling 0.0010843276977539062
▁and 1.1416015625
▁inclus 6.69921875
ive 0.003185272216796875
, 2.140625
▁as 2.107421875
▁it 0.384521484375
▁contains 4.94140625
▁direct 6.48828125
▁responses 4.609375
▁from 0.8818359375
▁a 3.908203125
▁large 1.177734375
▁number 0.52392578125
▁of 0.00536346435546875
▁participants 1.40625
. 0.72119140625
▁All 4.69140625
▁tools 8.9140625
▁in 4.52734375
▁the 0.65576171875
▁form 4.43359375
▁of 0.0726318359375
▁question 1.98828125
na 0.045440673828125
ires 0.00021088123321533203
▁and 2.3671875
▁scales 2.55859375
▁have 3.5234375
▁already 4.4765625
▁been 0.20166015625
▁used 1.921875
▁and 2.392578125
▁proved 4.47265625
▁their 2.3671875
▁effic 3.521484375
acy 0.0003504753112792969
▁for 3.583984375
▁collect 5.34375
ing 0.06817626953125
▁analyt 8.2578125
ical 0.322021484375
▁data 0.387939453125
. 0.580078125
▁It 3.658203125
▁helps 5.0546875
▁to 0.95849609375
▁system 7.328125
at 1.1240234375
ize 0.00800323486328125
▁and 1.5546875
▁class 3.640625
ify 0.002529144287109375
▁distinct 9.3671875
▁kinds 6.265625
▁of 0.036834716796875
▁information 3.958984375
▁for 3.796875
▁subsequent 4.26171875
▁un 7.80078125
comp 5.51171875
licated 0.1636962890625
▁services 11.1875
. 0.71923828125
▁The 1.3349609375
▁analysis 5.03125
▁of 0.6787109375
▁any 8.453125
▁human 6.390625
▁reaction 4.6171875
▁has 4.48046875
▁a 1.87109375
▁high 3.95703125
▁potential 3.380859375
▁of 1.6279296875
▁subject 7.3359375
iveness 4.05859375
▁and 1.1875
▁bias 3.080078125
, 1.4658203125
▁especially 2.849609375
▁regarding 4.359375
▁people 4.6328125
▁in 3.896484375
▁severe 4.37890625
▁pain 0.2958984375
▁and 2.748046875
▁un 5.25390625
stable 2.654296875
▁emot 1.064453125
ional 0.177490234375
▁condition 2.384765625
. 0.1319580078125
▁Thus 3.546875
, 0.027923583984375
▁research 4.54296875
ers 0.472900390625
▁can 3.52734375
▁compare 5.1953125
▁the 0.86181640625
▁effects 3.123046875
▁of 0.0848388671875
▁medic 4.6796875
ations 1.05078125
▁on 1.8115234375
▁patients 2.12890625
▁of 4.0859375
▁diverse 4.6015625
▁age 2.98828125
▁groups 0.83349609375
, 1.08203125
▁background 5.1953125
s 0.31982421875
, 0.07928466796875
▁physical 5.55078125
▁conditions 1.890625
, 0.11328125
▁emot 4.33984375
ional 0.052001953125
▁states 1.8525390625
, 0.1324462890625
▁and 0.450439453125
▁so 3.384765625
▁on 1.01171875
. 0.142822265625
▁Perhaps 8.59375
▁some 5.03515625
▁patients 2.333984375
▁tend 6.15234375
▁to 0.03424072265625
▁ex 5.53125
agger 0.0230712890625
ate 0.0149078369140625
▁their 0.88818359375
▁de 4.9453125
press 1.2373046875
ive 0.4423828125
▁state 3.345703125
▁or 2.27734375
▁vice 7.28515625
▁vers 0.0176544189453125
a 0.0015201568603515625
, 1.1748046875
▁de 7.25390625
- 5.0390625
emph 1.564453125
as 0.006320953369140625
ize 0.34912109375
▁serious 6.58984375
▁difficulties 6.3046875
. 0.8955078125
▁More 6.2890625
▁accurate 4.16015625
▁answers 4.3203125
▁could 3.9765625
▁be 0.67138671875
▁obtained 1.1923828125
▁by 1.3955078125
▁professional 7.12890625
▁psych 2.353515625
olog 0.395751953125
ists 0.00864410400390625
▁via 7.3046875
▁personal 4.73828125
▁communication 4.77734375
▁and 1.8251953125
▁behavior 6.7578125
al 0.325927734375
▁analysis 2.7734375
. 0.328369140625
▁Because 6.609375
▁the 1.61328125
▁survey 6.65234375
▁responses 6.66796875
▁were 1.6826171875
▁thoroughly 8.28125
▁anonymous 5.1171875
, 0.453125
▁the 1.337890625
▁research 1.943359375
ers 0.3466796875
▁were 1.2568359375
▁unable 2.8515625
▁to 0.005191802978515625
▁carefully 8.9375
▁analyze 1.498046875
▁each 4.015625
▁patient 2.1484375
’ 26.5
s 1.103515625
▁reaction 4.30859375
▁and 2.501953125
▁compare 3.703125
▁it 1.078125
▁to 1.1806640625
▁the 0.75634765625
▁actual 6.15625
▁states 7.625
▁of 0.52490234375
▁condition 7.37890625
. 0.492431640625
▁However 2.41015625
, 0.002353668212890625
▁this 2.7265625
▁method 3.341796875
▁of 2.298828125
▁research 2.48046875
▁is 1.7509765625
▁way 9.359375
▁more 0.447509765625
▁resource 7.26171875
- 2.24609375
int 1.24609375
ensive 0.01026153564453125
▁and 0.9462890625
▁energy 8.6328125
- 0.11956787109375
consum 0.388427734375
ing 0.0183258056640625
. 0.982421875
▁Part 5.29296875
icip 0.1842041015625
ants 0.08050537109375
▁were 0.93701171875
▁rec 2.228515625
ru 0.0005831718444824219
ited 3.6716461181640625e-05
▁for 0.86083984375
▁six 0.299560546875
▁months 0.011260986328125
▁at 0.1944580078125
▁two 0.047088623046875
▁major 0.06787109375
▁pain 0.01006317138671875
▁relief 0.0107269287109375
▁cent 0.006999969482421875
ers 0.006542205810546875
▁in 0.027069091796875
▁Israel 0.0245208740234375
. 0.08392333984375
▁All 4.01953125
▁patients 2.0234375
▁experienced 6.07421875
▁chron 2.04296875
ic 0.00316619873046875
▁pain 0.0714111328125
▁for 3.6953125
▁at 0.83544921875
▁least 0.0016679763793945312
▁ 0.9462890625
3 1.3935546875
▁months 0.42138671875
. 0.96142578125
▁The 1.4697265625
▁study 1.4306640625
▁included 2.88671875
▁ 0.98046875
8 2.751953125
9 2.845703125
0 3.59375
▁participants 1.4775390625
, 1.384765625
▁of 1.7255859375
▁which 0.43798828125
▁ 0.1629638671875
4 1.71484375
7 2.443359375
4 2.779296875
▁( 2.115234375
5 0.11834716796875
9 12.125
%) 0.8447265625
▁were 0.52978515625
▁treated 4.4609375
▁sole 6.9765625
ly 0.0027256011962890625
▁with 0.440673828125
▁op 0.85791015625
io 0.39111328125
ids 0.27587890625
, 1.2529296875
▁ 0.6650390625
3 1.1640625
2 2.146484375
9 2.521484375
▁( 0.056854248046875
4 0.63623046875
1 1.21484375
%) 0.307861328125
▁were 1.283203125
▁treated 0.421142578125
▁with 0.2213134765625
▁MM 0.75146484375
, 0.364013671875
▁and 0.210693359375
▁ 0.132568359375
7 3.2109375
7 2.3984375
▁( 0.2529296875
8 3.939453125
. 0.441162109375
6 3.236328125
%) 0.2210693359375
▁acquired 9.671875
▁both 1.244140625
▁( 6.85546875
Fe 9.21875
ing 2.841796875
old 0.058349609375
▁et 1.8310546875
▁al 0.0999755859375
., 0.372314453125
▁ 0.015838623046875
2 0.382568359375
0 0.0006227493286132812
1 0.5830078125
7 2.181640625
). 0.25390625
▁Therefore 5.25390625
, 0.0082244873046875
▁it 2.490234375
▁is 0.88916015625
▁not 2.75390625
▁possible 2.03515625
▁to 0.0343017578125
▁compreh 6.5703125
ens 0.0172119140625
ively 0.01320648193359375
▁compare 1.9072265625
▁patients 4.48046875
▁taking 3.966796875
▁medic 3.98828125
ations 0.499755859375
▁with 1.240234375
▁those 1.52734375
▁who 1.2265625
▁do 1.61328125
▁not 0.01282501220703125
. 0.86474609375
▁The 1.7470703125
▁remaining 7.40625
▁ten 8.9921875
▁participants 2.294921875
▁who 4.51953125
▁did 1.298828125
▁not 0.0086517333984375
▁receive 1.537109375
▁ph 3.05859375
arma 0.0308380126953125
ce 0.0019426345825195312
ut 1.7762184143066406e-05
ical 0.01361083984375
▁op 1.140625
io 0.0780029296875
ids 0.0291290283203125
▁and 1.6865234375
▁medical 2.40234375
▁mar 0.0562744140625
iju 0.0096893310546875
ana 0.00010132789611816406
▁were 1.3876953125
▁with 6.68359375
dra 0.07318115234375
wn 4.470348358154297e-05
▁from 0.342041015625
▁the 0.119384765625
▁analysis 4.5625
▁in 4.50390625
▁the 1.2412109375
▁research 4.4453125
. 0.8759765625
▁The 1.2958984375
▁study 1.66015625
▁conducted 4.56640625
▁a 2.28125
▁correlation 6.17578125
▁type 7.0390625
▁of 0.70703125
▁research 2.162109375
▁with 2.8203125
▁variable 8.0078125
▁measures 4.8125
. 1.556640625
▁For 3.91796875
▁example 1.248046875
, 0.0233001708984375
▁the 1.3154296875
▁survey 5.63671875
▁showed 4.8125
▁that 0.56396484375
▁the 1.8662109375
▁ratio 6.72265625
▁of 0.11834716796875
▁female 4.703125
▁patients 0.9306640625
▁was 1.783203125
▁remark 9.6015625
ably 0.0007414817810058594
▁higher 0.599609375
▁in 2.658203125
▁the 0.78759765625
▁op 4.87890625
i 3.736328125
ates 0.2200927734375
▁group 0.349365234375
▁compared 2.73828125
▁to 0.201171875
▁the 0.5439453125
▁MM 0.475341796875
▁group 0.40283203125
. 0.5439453125
▁It 3.015625
▁evaluated 9.640625
▁the 0.5537109375
▁inter 7.0234375
dep 3.201171875
end 0.004016876220703125
ence 0.006237030029296875
▁of 0.501953125
▁various 4.17578125
▁factors 1.6962890625
▁that 2.36328125
▁affected 3.494140625
▁the 0.57177734375
▁physical 6.98046875
▁and 0.71875
▁emot 0.55615234375
ional 0.00032210350036621094
▁condition 1.1962890625
▁of 0.2105712890625
▁patients 0.646484375
▁experien 4.26953125
cing 4.184246063232422e-05
▁chron 0.35400390625
ic 0.0006880760192871094
▁pain 0.0258941650390625
. 0.242919921875
▁In 3.185546875
▁turn 5.4453125
, 0.006473541259765625
▁people 6.26953125
▁on 4.63671875
▁op 1.86328125
i 0.8232421875
ates 0.0103607177734375
▁were 1.7197265625
▁more 1.349609375
▁likely 0.48388671875
▁to 0.05426025390625
▁report 2.990234375
▁major 6.05859375
▁de 0.595703125
press 1.10546875
ive 0.0027446746826171875
▁dis 0.54150390625
orders 1.431640625
. 1.890625
▁The 1.7607421875
▁question 5.5546875
na 1.72265625
ires 0.00039958953857421875
▁used 2.51171875
▁different 7.328125
▁variable 8.5
▁measures 0.986328125
▁to 1.482421875
▁collect 2.09765625
▁information 2.078125
. 1.794921875
▁For 2.1171875
▁example 0.1258544921875
, 0.00933837890625
▁it 3.986328125
▁included 3.2890625
▁compreh 8.6171875
ensive 0.058380126953125
▁so 6.640625
cio 0.02545166015625
- 0.7353515625
dem 0.177490234375
ographic 0.07080078125
▁data 1.3232421875
: 5.68359375
▁gender 1.5087890625
, 0.1092529296875
▁age 0.278076171875
, 0.098876953125
▁country 3.986328125
, 1.2900390625
▁type 4.296875
▁of 0.075927734375
▁residence 3.7265625
▁( 3.373046875
urban 2.341796875
/ 2.7578125
r 0.04840087890625
ural 0.0007619857788085938
), 0.403076171875
▁years 6.1328125
▁of 0.20947265625
▁education 0.8330078125
, 0.1959228515625
▁and 1.9267578125
▁employ 3.8203125
ment 0.0080718994140625
▁status 0.4453125
. 0.23193359375
▁Pat 3.951171875
ients 0.11492919921875
▁were 1.2421875
▁also 1.029296875
▁asked 0.873046875
▁about 1.1142578125
▁their 0.65673828125
▁medical 2.91796875
▁history 0.4921875
▁over 8.8046875
▁the 0.210693359375
▁years 3.814453125
▁and 1.904296875
▁the 1.904296875
▁current 3.42578125
▁presence 5.66015625
▁of 0.061553955078125
▁any 2.61328125
▁severe 4.4921875
▁dise 1.6875
ases 0.0001671314239501953
▁such 4.203125
▁as 0.00621795654296875
▁heart 2.46484375
▁failure 2.01171875
, 0.2257080078125
▁di 1.783203125
ab 0.0030384063720703125
etes 0.003940582275390625
, 0.1612548828125
▁ar 3.79296875
th 1.3701171875
rit 0.07818603515625
is 0.15185546875
, 0.052734375
▁and 1.65625
▁so 0.90771484375
▁on 0.06304931640625
. 0.069091796875
▁In 3.015625
▁addition 0.68017578125
, 0.14501953125
▁the 1.244140625
▁record 8.484375
▁included 1.8623046875
▁a 2.69921875
▁pain 5.72265625
▁measurement 4.671875
▁scale 1.064453125
▁from 3.5859375
▁ 0.39404296875
0 0.46240234375
▁to 0.5537109375
▁ 0.0110931396484375
1 0.061859130859375
0 0.0810546875
▁to 4.42578125
▁evaluate 1.4443359375
▁dis 5.640625
com 0.3447265625
fort 0.00226593017578125
▁feelings 7.76171875
▁during 3.529296875
▁the 0.9306640625
▁last 1.833984375
▁month 1.6357421875
. 0.276611328125
▁The 1.42578125
▁third 5.875
▁measure 4.40234375
▁of 2.333984375
▁the 1.017578125
▁question 3.044921875
naire 0.07257080078125
▁was 1.0419921875
▁indicated 10.390625
▁by 0.8857421875
▁information 6.69140625
▁on 1.4560546875
▁any 5.39453125
▁twelve 13.2578125
- 1.1806640625
month 1.025390625
▁and 5.87890625
▁lifetime 3.87109375
▁drug 4.49609375
▁and 3.505859375
▁alco 0.213134765625
hol 0.00036454200744628906
▁consumption 2.841796875
. 0.5478515625
▁Among 6.6015625
▁all 2.662109375
▁participants 1.7021484375
▁in 3.923828125
▁the 0.27490234375
▁study 0.65087890625
, 0.08734130859375
▁ 0.662109375
4 2.044921875
2 2.53125
. 1.4453125
2 2.224609375
% 0.2362060546875
▁suffered 5.078125
▁from 0.13671875
▁de 1.6513671875
pression 0.1390380859375
, 1.134765625
▁and 1.6220703125
▁ 0.15185546875
3 1.7041015625
7 2.3203125
% 2.373046875
▁experienced 2.287109375
▁excess 7.7578125
ive 0.100830078125
▁anx 0.33349609375
iety 0.00263214111328125
. 0.354248046875
▁The 1.4267578125
▁pl 11.0546875
ur 2.13671875
ality 0.0033435821533203125
▁of 0.2139892578125
▁anx 5.93359375
iety 0.0160980224609375
▁contained 10.2734375
▁ 1.0439453125
4 1.986328125
8 2.51953125
. 0.383544921875
4 2.26171875
% 0.1943359375
▁among 3.30078125
▁OP 9.4453125
▁patients 1.025390625
, 1.1279296875
▁ 0.712890625
2 1.6953125
1 2.546875
. 0.2431640625
5 2.2890625
% 0.02557373046875
▁among 0.378662109375
▁MM 0.088623046875
▁patients 0.2578125
, 0.065185546875
▁and 0.0830078125
▁ 0.08734130859375
3 1.625
8 2.79296875
. 0.283203125
7 2.345703125
% 0.01953125
▁among 0.320068359375
▁OP 4.6484375
MM 5.6171875
▁participants 3.01171875
. 0.2493896484375
▁The 1.3486328125
▁pl 3.90234375
ur 0.1273193359375
ality 0.00019431114196777344
▁of 0.08172607421875
▁de 0.6689453125
press 2.84765625
ive 0.0168304443359375
▁dis 1.7626953125
orders 0.10174560546875
▁among 3.25390625
▁patients 1.6240234375
▁in 3.76953125
▁the 0.51904296875
▁op 4.3046875
i 1.4033203125
ates 0.0163116455078125
, 5.91796875
▁medical 2.5
▁mar 0.050323486328125
iju 0.0313720703125
ana 4.935264587402344e-05
, 0.08514404296875
▁and 0.0531005859375
▁mixed 6.12109375
▁OP 5.265625
MM 0.32275390625
▁groups 0.47705078125
▁number 7.24609375
ed 0.014984130859375
▁ 0.0860595703125
5 2.404296875
7 2.59765625
. 0.1552734375
1 2.33984375
%, 0.221435546875
▁ 0.0038890838623046875
2 2.013671875
2 2.302734375
. 0.2012939453125
3 2.23828125
%, 0.12432861328125
▁and 0.026397705078125
▁ 0.0026531219482421875
5 2.431640625
1 2.150390625
. 0.251708984375
4 2.212890625
%, 0.307861328125
▁respectively 0.01076507568359375
. 0.1990966796875
▁Pat 4.921875
ients 0.041015625
▁who 2.373046875
▁took 3.06640625
▁strong 7.6015625
▁op 1.802734375
i 1.369140625
ates 0.0091705322265625
▁were 1.7861328125
▁t 8.6328125
ended 1.0771484375
▁to 0.024078369140625
▁place 9.7890625
▁their 3.625
▁pain 2.5859375
▁on 3.4453125
▁a 0.82177734375
▁scale 2.20703125
▁of 0.56982421875
▁ 0.411376953125
9 2.80078125
▁to 1.330078125
▁ 0.0222930908203125
1 0.046142578125
0 0.1468505859375
▁( 2.544921875
Fe 1.7373046875
ing 0.1602783203125
old 0.0012006759643554688
▁et 0.0450439453125
▁al 0.006626129150390625
., 0.01461029052734375
▁ 0.0023021697998046875
2 0.0012407302856445312
0 3.802776336669922e-05
1 0.0038051605224609375
7 0.0178070068359375
). 0.1427001953125
▁They 4.06640625
▁were 1.494140625
▁also 1.6513671875
▁an 8.2421875
gu 5.0859375
ished 0.044036865234375
▁em 8.234375
otion 0.01947021484375
ally 0.005084991455078125
▁and 1.1748046875
▁react 6.99609375
ed 0.11474609375
▁rad 9.4140625
ically 0.0034046173095703125
▁neg 5.05078125
atively 0.00104522705078125
▁to 0.460693359375
▁almost 5.1015625
▁all 1.2177734375
▁survey 8.6171875
▁questions 0.7646484375
. 0.364501953125
▁Pat 3.876953125
ients 0.01464080810546875
▁who 1.384765625
▁took 1.5146484375
▁only 5.43359375
▁MM 0.93310546875
▁or 3.470703125
▁mixed 3.24609375
▁medic 2.703125
ations 0.42138671875
▁course 12.3125
▁had 2.47265625
▁a 1.236328125
▁significantly 2.583984375
▁more 3.974609375
▁stable 3.625
▁emot 1.1181640625
ional 0.005153656005859375
▁state 1.0966796875
▁and 1.4716796875
▁cop 5.5859375
ed 1.2646484375
▁with 0.68017578125
▁pain 1.4931640625
▁more 1.703125
▁manage 6.703125
able 2.39453125
. 0.61962890625
▁One 5.7265625
▁of 1.103515625
▁the 0.035064697265625
▁major 2.9375
▁limitations 3.41015625
▁is 3.35546875
▁the 0.6240234375
▁ins 4.68359375
u 0.043792724609375
fficient 0.12176513671875
ly 4.41796875
▁high 2.96875
▁response 3.142578125
▁rate 0.201904296875
, 2.185546875
▁ 4.86328125
5 2.052734375
7 1.8828125
% 1.9189453125
▁instead 7.015625
▁of 0.0096588134765625
▁ 0.58984375
7 1.6298828125
0 1.6826171875
% 1.197265625
▁( 1.50390625
Fe 0.2841796875
ing 0.059295654296875
old 0.0015668869018554688
▁et 0.006900787353515625
▁al 0.0030345916748046875
., 0.009033203125
▁ 0.001880645751953125
2 0.0005669593811035156
0 6.246566772460938e-05
1 0.0014467239379882812
7 0.0085906982421875
). 0.0938720703125
▁It 3.044921875
▁can 3.423828125
▁be 0.50927734375
▁fairly 7.96875
▁explained 2.458984375
▁by 0.263427734375
▁the 0.364501953125
▁weak 7.84375
▁focus 7.17578125
▁of 0.60498046875
▁respond 5.875
ents 0.125244140625
▁who 3.443359375
▁have 3.814453125
▁overcome 7.96875
▁severe 2.40625
▁pain 0.673828125
▁sens 8.1640625
ations 1.525390625
▁and 1.3115234375
▁de 4.078125
press 1.6611328125
ive 0.269287109375
▁episodes 3.857421875
. 0.68408203125
▁It 3.203125
▁is 0.97509765625
▁not 2.70703125
▁clear 4.4140625
▁how 1.7490234375
▁to 3.513671875
▁use 5.30078125
▁these 3.037109375
▁statistics 3.896484375
, 2.802734375
▁as 1.75390625
▁they 1.4345703125
▁still 6.10546875
▁may 5.0859375
▁be 1.48828125
▁relevant 5.67578125
▁for 1.451171875
▁the 1.935546875
▁overall 4.91796875
▁analysis 3.443359375
. 1.2138671875
